118 related articles for article (PubMed ID: 25257510)
1. Expression of programmed death 1 is correlated with progression of osteosarcoma.
Zheng W; Xiao H; Liu H; Zhou Y
APMIS; 2015 Feb; 123(2):102-7. PubMed ID: 25257510
[TBL] [Abstract][Full Text] [Related]
2. Programmed cell death 2 functions as a tumor suppressor in osteosarcoma.
Yang Y; Jin Y; Du W
Int J Clin Exp Pathol; 2015; 8(9):10894-900. PubMed ID: 26617804
[TBL] [Abstract][Full Text] [Related]
3. Expansion of a CD8(+)PD-1(+) replicative senescence phenotype in early stage CLL patients is associated with inverted CD4:CD8 ratios and disease progression.
Nunes C; Wong R; Mason M; Fegan C; Man S; Pepper C
Clin Cancer Res; 2012 Feb; 18(3):678-87. PubMed ID: 22190592
[TBL] [Abstract][Full Text] [Related]
4. Increased PD-1 expression on CD4+ and CD8+ T cells is involved in immune evasion in gastric cancer.
Saito H; Kuroda H; Matsunaga T; Osaki T; Ikeguchi M
J Surg Oncol; 2013 Apr; 107(5):517-22. PubMed ID: 23129549
[TBL] [Abstract][Full Text] [Related]
5. Evidence of Interleukin 21 Reduction in Osteosarcoma Patients Due to PD-1/PD-L1-Mediated Suppression of Follicular Helper T Cell Functionality.
Gao W; Zhou J; Ji B
DNA Cell Biol; 2017 Sep; 36(9):794-800. PubMed ID: 28650673
[TBL] [Abstract][Full Text] [Related]
6. Numbers of CD8+PD-1+ and CD4+PD-1+ Cells in Peripheral Blood of Patients with Chronic Lymphocytic Leukemia Are Independent of Binet Stage and Are Significantly Higher Compared to Healthy Volunteers.
Novák M; Procházka V; Turcsányi P; Papajík T
Acta Haematol; 2015; 134(4):208-14. PubMed ID: 26066608
[TBL] [Abstract][Full Text] [Related]
7. Suppressed Programmed Death 1 Expression on CD4
Bartosińska J; Zakrzewska E; Raczkiewicz D; Purkot J; Michalak-Stoma A; Kowal M; Krasowska D; Chodorowska G; Giannopoulos K
Mediators Inflamm; 2017; 2017():5385102. PubMed ID: 29180838
[TBL] [Abstract][Full Text] [Related]
8. [Expression and significance of PD-1 on CD4(+); and CD8(+); T cells from the peripheral blood of patients with systemic lupus erythematosus].
Wang Y; Xie C; Sun M; Chai J; Zhou Y; Chen Y; Tang J; Li B
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Sep; 29(9):962-5. PubMed ID: 24011159
[TBL] [Abstract][Full Text] [Related]
9. Menopausal status influences the expression of programmed death (PD)-1 and its ligand PD-L1 on immune cells from the human female reproductive tract.
Shen Z; Rodriguez-Garcia M; Patel MV; Barr FD; Wira CR
Am J Reprod Immunol; 2016 Aug; 76(2):118-25. PubMed ID: 27321759
[TBL] [Abstract][Full Text] [Related]
10. The expression of Tim-3 in peripheral blood of ovarian cancer.
Wu J; Liu C; Qian S; Hou H
DNA Cell Biol; 2013 Nov; 32(11):648-53. PubMed ID: 24007284
[TBL] [Abstract][Full Text] [Related]
11. The Expression of Programmed Death-1 on CD4+ and CD8+ T Lymphocytes in Patients with Type 2 Diabetes and Severe Sepsis.
Jia Y; Zhao Y; Li C; Shao R
PLoS One; 2016; 11(7):e0159383. PubMed ID: 27459386
[TBL] [Abstract][Full Text] [Related]
12. PD-1 expression defines two distinct T-cell sub-populations in follicular lymphoma that differentially impact patient survival.
Yang ZZ; Grote DM; Ziesmer SC; Xiu B; Novak AJ; Ansell SM
Blood Cancer J; 2015 Feb; 5(2):e281. PubMed ID: 25700246
[TBL] [Abstract][Full Text] [Related]
13. Expression of programmed death-1 in primary cutaneous CD4-positive small/medium-sized pleomorphic T-cell lymphoma, cutaneous pseudo-T-cell lymphoma, and other types of cutaneous T-cell lymphoma.
Cetinözman F; Jansen PM; Willemze R
Am J Surg Pathol; 2012 Jan; 36(1):109-16. PubMed ID: 21989349
[TBL] [Abstract][Full Text] [Related]
14. Decreased programmed death-1 expression on the T cells of patients with ankylosing spondylitis.
Zhou L; Zhang Y; Xu H; Hu L; Zhang C; Sun L; Xie Y; Lu H; Zhang Z; Hu W; Lin X
Am J Med Sci; 2015 Jun; 349(6):488-92. PubMed ID: 25881983
[TBL] [Abstract][Full Text] [Related]
15. Expression of programmed death-1 (PD-1) on CD4+ and CD8+ T cells in rheumatoid arthritis.
Li S; Liao W; Chen M; Shan S; Song Y; Zhang S; Song H; Yuan Z
Inflammation; 2014 Feb; 37(1):116-21. PubMed ID: 24062057
[TBL] [Abstract][Full Text] [Related]
16. The upregulation of programmed death 1 on peripheral blood T cells of glioma is correlated with disease progression.
Wei B; Wang L; Zhao X; Du C; Guo Y; Sun Z
Tumour Biol; 2014 Apr; 35(4):2923-9. PubMed ID: 24375192
[TBL] [Abstract][Full Text] [Related]
17. Rapid downregulation of programmed death-1 and interferon-γ-inducible protein-10 expression is associated with favourable outcome during antiviral treatment of chronic hepatitis B.
Hou FQ; Wu XJ; Wang Y; Chen J; Liu YZ; Ren YY; Song G; Ding YP; Yu M; Wang GQ
J Viral Hepat; 2013 Apr; 20 Suppl 1():18-26. PubMed ID: 23458521
[TBL] [Abstract][Full Text] [Related]
18. Decreased levels of alternative co-stimulatory receptors OX40 and 4-1BB characterise T cells from head and neck cancer patients.
Baruah P; Lee M; Odutoye T; Williamson P; Hyde N; Kaski JC; Dumitriu IE
Immunobiology; 2012 Jul; 217(7):669-75. PubMed ID: 22204816
[TBL] [Abstract][Full Text] [Related]
19. PD-1 blockage delays murine squamous cell carcinoma development.
Belai EB; de Oliveira CE; Gasparoto TH; Ramos RN; Torres SA; Garlet GP; Cavassani KA; Silva JS; Campanelli AP
Carcinogenesis; 2014 Feb; 35(2):424-31. PubMed ID: 24031027
[TBL] [Abstract][Full Text] [Related]
20. Dual control of antitumor CD8 T cells through the programmed death-1/programmed death-ligand 1 pathway and immunosuppressive CD4 T cells: regulation and counterregulation.
Currie AJ; Prosser A; McDonnell A; Cleaver AL; Robinson BW; Freeman GJ; van der Most RG
J Immunol; 2009 Dec; 183(12):7898-908. PubMed ID: 20007574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
